Medication Gives New Life to Aging Dogs?

This video is unavailable because we were unable to load a message from our sponsors.

If you are using ad-blocking software, please disable it and reload the page.

500 middle aged dogs will be included in a double-blind placebo-controlled trial of the drug rapamycin. The medication is currently FDA approved to prevent organ transplant rejection in people, but research shows it can expand the lifespan of mice. Could this help keep our furry friends around longer? A researcher from The Dog Aging Project Matt Kaeberlein weighs in.